GeneThera Enters Into Exclusive Collaboration Agreement with Hudson Robotics Inc.
Mar 04, 2015 09:38:00 (ET)
GeneThera Enters Into Exclusive Collaboration Agreement with Hudson Robotics Inc.
Collaboration with Hudson Robotics
WESTMINSTER, Colo., March 4, 2015 (GLOBE NEWSWIRE) -- GeneThera Inc. (OTC:GTHR) and Hudson Robotics Inc. announced today that they have entered into a worldwide exclusive collaboration agreement to develop the next generation of Integrated Automated Robotic Systems (IARS) molecular diagnostic platform for animal testing of Tuberculosis and Paratuberculosis. As part of the exclusive collaboration agreement, Hudson Robotics will receive a 10% equity ownership of GeneThera stock. Dr. Tony Milici, CEO of GeneThera, stated, "This collaboration agreement with Hudson Robotics, a world leading designer of Integrated Automation Robotic Systems, is a fundamental turning point for GeneThera. Hudson Robotics' and GeneThera's molecular diagnostic and robotic platform is the most advanced system designed to date for animal diagnostics. This platform has the potential of changing the way animal testing will be done in the future. Together with Hudson, we will build networks of laboratories anywhere in the world using IARS laboratory automated and informatics systems for the molecular diagnostics of animal diseases."
Phil Farrelly, President of Hudson Robotics, commented, "It is with great enthusiasm that we have entered into this exclusive collaboration agreement with GeneThera. Hudson Robotics has been on the forefront of integrated robotic automation, equipment and software development since 1983. GeneThera's animal molecular testing platform is a perfect fit for our integrated robotic technology. We believe that our close association with GeneThera's laboratory operations will further improve our ability to design and develop even more advanced integrated automation systems."
Mycobacterium Avium Paratuberculosis (MAP) is the causative agent of Johne's Disease also known as Paratuberculosis. Johne's Disease (JD) is a globally devastating incurable chronic inflammatory intestinal disease of dairy cow, sheep and goats. It has been estimated that over 70% of the dairy cowherd in the US alone are infected with MAP. A large number of studies have shown a relation between JD and Crohn's disease, a severe and possibly lethal chronic inflammatory disease of the human intestine. MAP is resistant to standard pasteurization procedures. Recent studies have also shown baby formula samples were positive for MAP infection.
" A rich man is not the one with the most! He is the one that needs the least!"
